Overview

Emergency Use of OCR-002 in Acute Liver Failure (ALF)

Status:
No longer available
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
This study provides emergency use of the unapproved study medication in ALF patients with acute liver failure who are not responding to standard of care.
Details
Lead Sponsor:
Ocera Therapeutics
Ocera Therapeutics, Inc.
Treatments:
Phenylacetic acid